Clear Harbor Asset Management, LLC Agenus Inc Transaction History

Clear Harbor Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$1.12 - $1.88 $1,680 - $2,820	-1,500 Reduced 3.89%	37,075 $41,000
Q1 2023 May 04, 2023	BUY	$1.45 - $2.95 $55,933 - $113,796	38,575 New	38,575 $58,000
Q4 2020 Feb 04, 2021	SELL	$3.17 - $4.49 $792 - $1,122	-250 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$2.98 - $5.2 $745 - $1,300	250 New	250 $1,000
Q1 2020 May 08, 2020	SELL	$1.92 - $4.39 $480 - $1,097	-250 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$2.41 - $4.4 $602 - $1,100	250 New	250 $1,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.